131 related articles for article (PubMed ID: 34382511)
1. SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway.
Shrestha J; Shamshiddinova M; Lee YM; Oh YS; Baek DJ; Park EY
Curr Mol Pharmacol; 2022; 15(3):570-581. PubMed ID: 34382511
[TBL] [Abstract][Full Text] [Related]
2. Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure.
Shrestha J; Kim SW; Kim SB; Oh YS; Ki SH; Lee T; Kim SB; Park T; Baek DJ; Park EY
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057052
[TBL] [Abstract][Full Text] [Related]
3. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.
Baran Y; Salas A; Senkal CE; Gunduz U; Bielawski J; Obeid LM; Ogretmen B
J Biol Chem; 2007 Apr; 282(15):10922-34. PubMed ID: 17303574
[TBL] [Abstract][Full Text] [Related]
4. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration.
Gao P; Smith CD
Mol Cancer Res; 2011 Nov; 9(11):1509-19. PubMed ID: 21896638
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
Adams DR; Pyne S; Pyne NJ
Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
[TBL] [Abstract][Full Text] [Related]
6. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
7. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
8. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis.
Taha TA; Kitatani K; El-Alwani M; Bielawski J; Hannun YA; Obeid LM
FASEB J; 2006 Mar; 20(3):482-4. PubMed ID: 16507765
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
[TBL] [Abstract][Full Text] [Related]
10. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
11. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.
Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
J Biol Chem; 2006 Mar; 281(13):8518-27. PubMed ID: 16415355
[TBL] [Abstract][Full Text] [Related]
12. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
[TBL] [Abstract][Full Text] [Related]
13. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Beljanski V; Knaak C; Smith CD
J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
[TBL] [Abstract][Full Text] [Related]
14. Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells.
Momchilova A; Nikolaev G; Pankov S; Vassileva E; Krastev N; Robev B; Krastev D; Pinkas A; Pankov R
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430423
[TBL] [Abstract][Full Text] [Related]
15. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia.
You B; Ren A; Yan G; Sun J
Diabetes; 2007 May; 56(5):1445-53. PubMed ID: 17325258
[TBL] [Abstract][Full Text] [Related]
16. Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides.
Trayssac M; Clarke CJ; Stith JL; Snider JM; Newen N; Gault CR; Hannun YA; Obeid LM
Cell Death Dis; 2021 Jan; 12(1):27. PubMed ID: 33414460
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.
Taha TA; Osta W; Kozhaya L; Bielawski J; Johnson KR; Gillanders WE; Dbaibo GS; Hannun YA; Obeid LM
J Biol Chem; 2004 May; 279(19):20546-54. PubMed ID: 14988393
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD
J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.
Abdel Hadi L; Di Vito C; Marfia G; Ferraretto A; Tringali C; Viani P; Riboni L
PLoS One; 2015; 10(11):e0143384. PubMed ID: 26580959
[TBL] [Abstract][Full Text] [Related]
20. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
